Personalized Nutrition Delivery to Improve Resilience in Older Adult Trauma Patients (SeND Home)

May 6, 2026 updated by: Duke University

Personalized Targeted Nutrition Via StructurEd Nutrition Delivery Pathway to Improve Resilience in Older Adult Trauma Patients

This is a Pilot study designed to set up for an randomized clinical trial (RCT) comparing the SeND Home pathway to a standard of care nutrition delivery in critically ill older adult trauma patients. Subjects will be randomized 3:1 to either SeND Home precision nutrition pathway or control arm. Subjects randomized to the SeND Home arm will receive oral nutrition supplements (ONS) up to 3 times per day while in the hospital and for 4 weeks after discharge. Subjects in the standard of care arm will receive normal nutrition recommendations from their clinical providers. Participants in both groups will undergo non-invasive tests that measure how much energy (calories) they are using, body composition, and muscle mass.

Study Overview

Status

Completed

Detailed Description

This is a Pilot study designed to set up for an randomized clinical trial (RCT) comparing the SeND Home pathway to a standard of care nutrition delivery in critically ill older adult trauma patients. The SeND Home Pathway supports patients from ICU admission to 2-weeks post-hospital discharge, providing a comprehensive and personalized plan of care carried to completion.

Subjects will be randomized 3:1 to either SeND Home precision nutrition pathway or control arm. Subjects randomized to the SeND Home arm will receive oral nutrition supplements (Ensure shakes) up to 3 times per day while in the hospital and for 4 weeks after discharge. Some subjects in this arm will be asked to participate in an interview after being discharged from the hospital. Subjects in the standard of care arm will receive normal nutrition recommendations from their clinical providers.

Participants in both groups will undergo non-invasive tests that measure how much energy (calories) they are using, body composition, and muscle mass. They will also be asked to complete walking and strength tests, and surveys about quality of life.These will be done every 3-7 days during hospitalization, at hospital discharge, and at a 3 month post-discharge follow-up visit.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Durham, North Carolina, United States, 27710
        • Duke University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients who are at least 60 years old and admitted to the trauma service
  • Patients who have had a standard of care CT scan

Exclusion Criteria:

  • Expected withdrawal of life-sustaining treatment within 48 hours
  • Prisoners
  • Unable to provide informed consent
  • Non-English speakers
  • Traumatic Brain Injury
  • Allergic to milk or soy ingredients (Common allergen in Ensure shakes).
  • Pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control pathway
Standard of care nutrition delivery throughout hospitalization. Upon discharge they will be sent home with standard nutrition information without Indirect Calorimetry (IC) guidance.
Experimental: SeND Home precision nutrition pathway
Oral nutrition supplements (ONS) will be given, at maximum, three times per day throughout hospitalization. Upon discharge, participants will be given 4-weeks' worth of oral supplements to take. Adjustments may be made based on indirect calorimetry (IC) measurements by the clinical dietitian.
Ensure shakes will be take up to 3 times a day throughout hospitalization and for 4 weeks after discharge.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Patients Recruited
Time Frame: Baseline
This outcome is a measure of feasibility of the SeND Home pathway
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Study Participants Who Adhere to the SeND Home Treatment Protocol
Time Frame: approximately 98 days
This outcome is a measure of feasibility of the SeND Home pathway
approximately 98 days
Percentage of Participants Retained to Study Completion
Time Frame: hospital stay plus 90 days
This outcome is a measure of feasibility of the SeND Home pathway
hospital stay plus 90 days
Time to Complete Each Outcome
Time Frame: 3 months
This outcome is an assessment of feasibility (participant burden)
3 months
How Well Outcome Assessments Are Tolerated
Time Frame: 3 months
This outcome is an assessment of feasibility (participant burden)
3 months
Duration of Testing Time
Time Frame: 3 months
This outcome is an assessment of feasibility (participant burden)
3 months
Ability to Successfully Complete Testing in One Cycle Will be Recorded
Time Frame: 3 months
This outcome is an assessment of feasibility (participant burden)
3 months
Provider Satisfaction With SeND Home
Time Frame: 18 months
This outcome is a measure of acceptability and will be used to iteratively adapt the SeND home design as progress throughout the study
18 months
Provider Assessment of Usefulness of SeND Home
Time Frame: 18 months
This outcome is a measure of acceptability and will be used to iteratively adapt the SeND home design as progress throughout the study
18 months
Number of Interventions Delivered Per Protocol in the ICU, on the Floor, and In-home
Time Frame: 18 months
The outcome is a measure of the fidelity of SeND Home
18 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Krista Haines, MD, Duke University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 5, 2023

Primary Completion (Actual)

February 1, 2024

Study Completion (Actual)

July 26, 2024

Study Registration Dates

First Submitted

September 14, 2022

First Submitted That Met QC Criteria

September 14, 2022

First Posted (Actual)

September 16, 2022

Study Record Updates

Last Update Posted (Actual)

June 2, 2026

Last Update Submitted That Met QC Criteria

May 6, 2026

Last Verified

September 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Critical Illness

Clinical Trials on Nutrition supplement - Ensure shakes

Subscribe